High Purity CAS 83799-24-0 Fexofenadine HCl Raw Material Fexofenadine

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: QS-Fexofenadine
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Fexofenadine
• Name: Fexofenadine Powder
• Appearance: White Powder
• Colour: White
• Grade: Pharmaceutical Grade
• Assay: >99%
• Application: API
• Specific: COA
• Test Method: HPLC
• Mf: C32h39no4
• MW: 501.65636
• CAS: 83799-24-0
• Density: 1.171
• Melting Point: 218-220c
• Boiling Point: 760 Mmhg
• Transport Package: Negotiable
• Specification: >99%
• Trademark: QS-Fexofenadine
• Origin: Xian
• Production Capacity: 10000kg/Month

Product Description

High Purity CAS 83799-24-0 Fexofenadine HCl Raw Material Fexofenadine

Product Description

Product Details

Product Name	Fexofenadine
Appearance	White Powder
Assay	99%
MW	501.65636
MF	C32H39NO4

Fexofenadine is a second-generation antihistamine drug mainly used to treat allergic diseases such as allergic rhinitis and chronic urticaria. The main mechanism of action of fexofenadine is to block the histamine H1 receptor, reduce histamine release and action, thereby alleviating symptoms caused by allergic reactions. Histamine is an important biogenic amine substance that plays a crucial role in the body's immune response. When the body comes into contact with allergens, mast cells release histamine, leading to a series of reactions such as vasodilation, tissue edema, and nerve excitation, which can cause allergic symptoms such as sneezing, runny nose, itching, etc. Fexofenadine selectively binds to the H1 histamine receptor in the body, blocking the biological activity of histamine and thereby alleviating allergic symptoms.

Application&Function

Indication
Fexofenadine is mainly used to treat the following allergic diseases:
Seasonal allergic rhinitis: Fexofenadine can effectively alleviate symptoms such as nasal congestion, runny nose, and sneezing in patients.
Chronic idiopathic urticaria: Clinical studies have shown that fexofenadine can significantly reduce the occurrence of itching and rash, and improve the quality of life of patients.
Efficacy evaluation
Numerous clinical studies have shown that fexofenadine has a significant alleviating effect on the aforementioned allergic symptoms, and has good safety and tolerability, making it widely used in clinical treatment.

Specification